http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
복강내 Cisplatin 주입요법에 의한 악성 복수 조절
정진민(Jin Min Chung),문한림(Han Lim Moon),홍영선(Young Seon Hong),박동준(Dong Jun Park),김훈교(Hoon Kyo Kim),이경식(Kyung Shik Lee),김동집(Dong Jip Kim),홍대식(Dae Shik Hong) 대한내과학회 1987 대한내과학회지 Vol.33 No.1
N/A A major problem of cancer chemoterapy is narrow therapeutic index. To overcome this problem, in patients with intraabdominal cancer metastasis, intraperitoneal instillation of cancer chemotherapeutic agent is tried and much higher concentration of chemotherapeutic agent could be exposed to cancer tissue. Sixteen patients with malignant acites with various kinds of cancer, such as stomach caner(9), ovarian cancer(2), hepatocelluar carcinoma(2) and malignacy of unknown origin(4), recieved a total of 23 courses of intraperitoneal cisplatin therapy, After confirmation of normal renal function and adequate hydration, ascites was drained completely. 90 mg/m² B.S.A. of cisplatin suspended in 2 liters of warm saline was in- stilled into the peritoneal cavity. After a single 4-hour dwelling, the solution was again drained as completely as possible. Of 12 evaluable patients, ascites did not recur in 3 patients for 1 month after therapy (complete control). Seven patients showed increased performance status and decreased abdominal girth and body weight (partial control). When ascites recurred, IP therapy was repeated. The toxicities were mild to moderate nausea and vomiting, diarrhea, abdominal pain, high fever and bone marrow suppression. There was no nephrotoxicity and neurotoxicity. We concluded intraperitoneal cisplatin therapy was effective for the control of malignant ascites and tolerable.